CN Patent

CN116390714A — 局部眼科组合物

Assigned to Ads Medical Co ltd · Expires 2023-07-04 · 3y expired

What this patent protects

一种局部眼科组合物，其包括治疗有效量的作为活性药物成分的毒蕈碱受体拮抗剂，和作为液体载剂的半氟化烷烃。所述局部眼科组合物治疗眼病。

USPTO Abstract

一种局部眼科组合物，其包括治疗有效量的作为活性药物成分的毒蕈碱受体拮抗剂，和作为液体载剂的半氟化烷烃。所述局部眼科组合物治疗眼病。

Drugs covered by this patent

phenylephrine-hydrochloride (PHENYLEPHRINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN116390714A
Jurisdiction: CN
Classification: —
Expires: 2023-07-04
Drug substance claim: No
Drug product claim: No
Assignee: Ads Medical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.